No Data
Kepler Capital Remains a Buy on Carmila SAS (CARM)
CARMILA: Information Concerning the Total Number of Voting Rights and Share
CARMILA: Information Concerning the Total Number of Voting Rights and Share, Provided Pursuant to Article L.233-8 II of the Code De Commerce (French Commercial Code) and Article 223-16 of the Règlement Général De L'Autorité Des Marchés Financiers ...
Carisma Announces Delisting From Nasdaq and SEC Deregistration
CARISMA Therapeutics Q3 EPS $1.07 Beats $(0.12) Estimate, Sales $45.250M Beat $3.771M Estimate
Carisma Therapeutics | 10-Q: Q3 2025 Earnings Report